DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
DarioHealth is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Blood sugar monitor is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. The company generates the majority of the revenue.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 9, 2022 | Post-IPO Debt | $50M | 1 | OrbiMed | — | Detail |
Jan 27, 2021 | Post-IPO Equity | $70M | 6 | — | — | Detail |
Jul 21, 2020 | Post-IPO Equity | $28.60M | 5 | — | — | Detail |
Oct 22, 2019 | Post-IPO Equity | $21.30M | 1 | — | — | Detail |
Sep 16, 2018 | Post-IPO Equity | $10.34M | — | — | — | Detail |
DarioHealth has acquired 3 organizations. Their most recent acquisition was Upright Technologies on Jan 27, 2021. They acquired Upright Technologies for $31M.
Date
Company Name
|
Industry | Acquisition Type | Price | |
---|---|---|---|---|
Jan 27, 2021
Upright Technologies
|
Health Care | acquisition | $ 31M | Detail |
May 18, 2021
wayForward
|
Health Care | acquisition | $ 25M | Detail |
Jan 20, 2022
PhysiMax Technologies
|
Artificial Intelligence | acquisition | $ 1.02M | Detail |